Executive Director of Insights and Analytics
Tango Therapeutics
Executive Director of Insights and Analytics
Tango Therapeutics
Develops synthetic-lethality cancer therapies
Company Overview
Tango Therapeutics is a biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer.
Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer.
This includes expanding the universe of precision oncology targets into novel areas such as tumor suppressor gene loss and their contribution to the ability of cancer cells to evade immune cell killing.
The Tango labs and offices are located at 201 Brookline Avenue, in the Fenway area of Boston, Massachusetts.
Summary
The Executive Director, Insights and Analytics (ED I&A) is a strategic enterprise leader responsible for building, scaling, and leading Tango Therapeutics’ Insights and Analytics center of excellence. As Tango transitions from a research-stage biotech into a fully integrated commercial organization, this executive will define the enterprise-wide data, analytics, and insights strategy to support the successful launch and lifecycle management of our precision synthetic lethality oral medicines.
Reporting directly to the Chief Commercialization Officer (CCO), the ED of I&A will serve as a critical member of the Commercial Leadership Team and cross-functional strategy teams. This leader will act as an indispensable thought partner to executive leadership, translating complex data ecosystems into actionable insights that influence enterprise direction, optimize performance, and drive data-driven decision-making across Sales, Marketing, Market Access, Medical Affairs, and Finance. The ED of I&A is responsible for building and mentoring a high-performing leadership team encompassing critical functions across Market Research, Forecasting, and a Data & Advanced Analytics Center of Excellence (COE).
Your Role:
Cross-Functional Leadership & Strategic Integration
Market Research & Competitive Intelligence
Forecasting & Demand Planning
Data Strategy & Advanced Analytics (COE)
What You Bring:
Education & Experience
Core Competencies
#LI-Hybrid
We are an equal opportunity employer and value diversity at our company. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.
Salary range 275200 - 412800 USD
Develops synthetic-lethality cancer therapies
Tango Therapeutics develops cancer medicines by leveraging synthetic lethality to selectively kill cancer cells while sparing healthy cells. Its approach focuses on creating drugs that exploit interactions between gene pairs, aiming for targeted therapies that spare normal tissue. The company advances its treatments through a strong R&D program and collaborates with larger pharmaceutical partners, such as Gilead Sciences, to co-develop therapies and accelerate commercialization. Revenue comes from these partnerships and funding rounds like its Series B. Tango differentiates itself with a dedicated emphasis on genetically targeted cancer therapies, a robust pipeline, and leadership that guides strategic collaborations. The company’s goal is to bring next-generation, genetically targeted immunotherapies to market, improving outcomes for cancer patients by precisely targeting tumor biology.
Explore more opportunities at Tango Therapeutics